Logos Global Management’s Belite Bio BLTE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$34M Sell
200,000
-50,000
-20% -$8.12M 1.83% 19
2026
Q2
$38.5M Buy
+250,000
New +$38.3M 1.66% 19

Other funds holding BLTE

Logos Global Management's BLTE Position: Q3 2026 in Review

Logos Global Management reduced its Belite Bio (BLTE) stake by 20% in Q3 2026, selling an estimated $8.12M and leaving 200,000 shares worth $34M. The position accounts for 1.83% of the portfolio, ranked #19.

Logos Global Management first reported a position in BLTE in Q2 2026 and has held it in 2 quarters since. The position peaked at $38.5M in Q2 2026. 96 funds tracked by Wall St. Rank hold BLTE as of Q3 2026.

  • Logos Global Management held 200,000 shares of Belite Bio worth $34M as of Q3 2026.
  • Logos Global Management sold 50,000 Belite Bio shares in Q3 2026, an estimated $8.12M.
  • Belite Bio made up 1.83% of Logos Global Management's portfolio in Q3 2026, its #19 holding.
  • Logos Global Management first reported a position in Belite Bio in Q2 2026 and has held it in 2 quarters since.
  • Logos Global Management's Belite Bio position peaked at $38.5M in Q2 2026.
  • 96 funds tracked by Wall St. Rank held Belite Bio as of Q3 2026.

Based on Logos Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.